4//SEC Filing
Dorenbaum Alejandro 4
Accession 0001209191-21-069439
CIK 0001637715other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 4:30 PM ET
Size
7.2 KB
Accession
0001209191-21-069439
Insider Transaction Report
Form 4
Dorenbaum Alejandro
Chief Medical Officer
Transactions
- Award
Common Stock
2021-12-10+30,000→ 52,348 total - Award
Stock option (right to buy)
2021-12-10+100,000→ 100,000 totalExercise: $6.69Exp: 2031-12-09→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit award.
- [F2]The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Persons's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.
Documents
Issuer
Reneo Pharmaceuticals, Inc.
CIK 0001637715
Entity typeother
Related Parties
1- filerCIK 0001606083
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 4:30 PM ET
- Size
- 7.2 KB